OTC NSAID use linked to increased risk of gastrointestinal bleeding in ACG's GI Registry.
This article was originally published in The Tan Sheet
Executive Summary
OTC NSAID LINK TO GI BLEEDING SUPPORTED BY DATA FROM GI REGISTRY developed by the American College of Gastroenterology under a grant from McNeil Consumer Products. Early data from the GI Registry -- essentially a physician survey that uses a control group for comparisons -- was presented at ACG's annual scientific meeting Oct. 16 in New York City.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: